Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus G Dalgleish

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
BJU International|August 5, 2004
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II studyHardev S Pandha, Robert J John, James Hutchinson, et al.
International Journal of Oncology|June 10, 2016
Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapyWai M Liu, Katherine A Scott, Jayne L Dennis, et al.
Immunology|April 21, 2004
Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infectionAnnapurna Vyakarnam, David Sidebottom, Shahed Murad, et al.
Journal of Immunological Methods|September 4, 2004
Successful live cell harvest from bisected sentinel lymph nodes research reportBruce Elliott, Martin G Cook, R Justin John, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunityKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Immunology|August 15, 2020
The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vδ2<sup>+</sup> γδ T cells in the modulation of immune response to tumour?Emma L Sparrow, Daniel W Fowler, Joe Fenn, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2010
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agentsAndrew M Gravett, Wai M Liu, Sanjeev Krishna, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2003
Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunityStephen M Todryk, Jonathan Eaton, Lindsay Birchall, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 28, 2016
Human Peritoneal Mesothelial Cells Display Phagocytic and Antigen-Presenting Functions to Contribute to Intraperitoneal ImmunityTanya J Shaw, Xiang Y Zhang, Zhiming Huo, et al.
Molecular and Clinical Oncology|October 2, 2020
Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapyEve Merry, Maria Marples, Sarah Danson, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
BJU International|August 5, 2004
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II studyHardev S Pandha, Robert J John, James Hutchinson, et al.
International Journal of Oncology|June 10, 2016
Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapyWai M Liu, Katherine A Scott, Jayne L Dennis, et al.
Immunology|April 21, 2004
Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infectionAnnapurna Vyakarnam, David Sidebottom, Shahed Murad, et al.
Journal of Immunological Methods|September 4, 2004
Successful live cell harvest from bisected sentinel lymph nodes research reportBruce Elliott, Martin G Cook, R Justin John, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunityKeith Dredge, J Blake Marriott, Stephen M Todryk, et al.
Immunology|August 15, 2020
The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vδ2<sup>+</sup> γδ T cells in the modulation of immune response to tumour?Emma L Sparrow, Daniel W Fowler, Joe Fenn, et al.
Cancer Chemotherapy and Pharmacology|May 22, 2010
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agentsAndrew M Gravett, Wai M Liu, Sanjeev Krishna, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2003
Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunityStephen M Todryk, Jonathan Eaton, Lindsay Birchall, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 28, 2016
Human Peritoneal Mesothelial Cells Display Phagocytic and Antigen-Presenting Functions to Contribute to Intraperitoneal ImmunityTanya J Shaw, Xiang Y Zhang, Zhiming Huo, et al.
Molecular and Clinical Oncology|October 2, 2020
Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapyEve Merry, Maria Marples, Sarah Danson, et al.
Pageof 9